Weight Loss
The Complete Guide to Medical Weight Loss for Women in Singapore
Min Read
Medically reviewed by Dr. Kevin Chua, Medical Director Last updated: April 2026
About the reviewer Dr. Kevin Chua — Medical Director, zoey™. Dr. Chua oversees clinical governance and ensures all treatment plans meet Singapore medical standards.
Medical weight loss has entered a new era with GLP-1 receptor agonists — and for women, these medications offer particular promise. Women face unique hormonal, metabolic, and social factors that make weight management challenging. From PCOS-related weight gain to post-pregnancy body changes and menopausal metabolism shifts, women's weight loss requires a nuanced, gender-aware approach. This guide covers everything Singaporean women need to know about medical weight loss.
Women face biological and social factors that make weight management uniquely challenging. Understanding these differences is essential for effective treatment.
GLP-1 (glucagon-like peptide-1) receptor agonists work by mimicking a natural gut hormone that regulates appetite and blood sugar. For women, these medications are particularly relevant because they address the hormonal hunger signals that make weight loss difficult.
Women were well-represented in GLP-1 clinical trials (typically 50–70% of participants). Key findings:
| Medication | Route | Frequency | Avg Weight Loss | Notes for Women |
|---|---|---|---|---|
| Semaglutide 2.4 mg (Wegovy) | Injection | Weekly | ~15% | Well-studied in women |
| Semaglutide 1.0 mg (Ozempic) | Injection | Weekly | ~10% | Lower dose option |
| Oral semaglutide (Rybelsus) | Tablet | Daily | ~8-10% | Needle-free option |
| Tirzepatide (Mounjaro) | Injection | Weekly | ~18-22% | Highest efficacy |
→ Read more: Rybelsus vs Ozempic for Women (SG-Z-WL-01) → Read more: Mounjaro for Women (SG-Z-WL-03)
GLP-1 medications interact with women's hormonal health in several important ways that require specific attention.
GLP-1 medications delay gastric emptying, which can theoretically reduce the absorption of oral contraceptive pills. While clinical evidence of actual contraceptive failure is limited, women on oral contraception should discuss this with their doctor. Options include:
→ Read more: GLP-1 and Contraception (SG-Z-WL-05)
GLP-1 medications are contraindicated during pregnancy. Women should: - Use reliable contraception while on treatment - Stop medication at least 2 months before planned conception (semaglutide) or as advised by their doctor - Inform their doctor immediately if pregnancy occurs during treatment
GLP-1 medications may offer particular benefits for women with PCOS by improving insulin sensitivity and promoting weight loss — both of which can improve hormonal balance, menstrual regularity, and fertility1.
Perimenopausal and menopausal women often experience metabolic changes that make weight loss harder. GLP-1 medications can be effective in this population, and the cardiovascular benefits are particularly relevant given increased cardiovascular risk after menopause.
→ Read more: Weight Loss During Menopause (SG-Z-WL-09)
Eligibility criteria for women are the same as for men, with the important addition of pregnancy-related considerations.
| Criteria | Eligible |
|---|---|
| BMI ≥27.5 (Asian obese) | Yes |
| BMI ≥25 + comorbidities (PCOS, diabetes, hypertension) | Yes |
| BMI <25 without comorbidities | Generally no |
zoey™ provides women's health services including medical weight loss through MOH-compliant telehealth. The process is designed to be thorough, supportive, and discreet.
| Medication | Monthly Cost (SGD) |
|---|---|
| Rybelsus (oral semaglutide) | S$300–450 |
| Ozempic (injectable semaglutide) | S$350–500 |
| Wegovy (semaglutide 2.4 mg) | S$500–700 |
| Mounjaro (tirzepatide) | S$400–650 |
zoey™ subscription plans may offer different pricing. Contact zoey™ for details.
| Week | What to Expect |
|---|---|
| 1–2 | Reduced appetite, possible nausea |
| 2–4 | Early weight loss (1–2 kg), appetite notably reduced |
| 4–8 | Consistent weight loss (0.5–1 kg/week) |
| 8–16 | Dose escalation continues; steady progress |
| 16–52 | Approaching maximum weight loss |
| Note | Menstrual cycle may cause weekly weight fluctuations of 1–2 kg — track monthly trends, not weekly |
Side effects are similar for women and men, primarily gastrointestinal. Most improve with time and dose adjustment.
→ Read more: GLP-1 Side Effects for Women (SG-Z-WL-04)
Yes. Women comprised a large proportion of clinical trial participants, and safety and efficacy were demonstrated across genders23. Women-specific considerations (contraception, pregnancy) require additional discussion with your doctor.
Some women report changes in menstrual patterns, but this is not well-studied. Weight loss itself can affect menstrual regularity. Report significant changes to your doctor.
GLP-1 medications are generally not recommended during breastfeeding due to limited safety data. Discuss timing with your doctor if you're planning to stop breastfeeding.
Facial volume loss can occur with significant weight loss (any method). Adequate protein intake, slower weight loss, and maintaining hydration can minimise this effect. It's not specific to GLP-1 medications.
Women with PCOS often respond well to GLP-1 medications. The improvement in insulin sensitivity is particularly beneficial for PCOS-related weight gain.
Yes. GLP-1 medications can be used alongside HRT for menopausal women. There are no significant drug interactions, but inform your doctor about all medications.
zoey™ is dedicated to women's health, with assessments, treatment plans, and support designed for women's specific needs. noah™ focuses on men's health. Both operate under the same clinical governance.
Rapid weight loss from any cause can trigger temporary hair shedding (telogen effluvium), typically 2–4 months after significant weight loss. It's not caused by the medication itself. Adequate protein intake and gradual weight loss minimise this risk.
Yes, but you must stop GLP-1 medication at least 2 months before trying to conceive. Weight loss before pregnancy can actually improve fertility outcomes, particularly for women with PCOS.
Yes, but discuss with your doctor. GLP-1 medications may reduce oral contraceptive absorption. Your doctor may recommend additional contraception or switching to a non-oral method.
This article is for informational purposes only and does not constitute medical advice. GLP-1 medications are prescription-only in Singapore. Always consult a licensed doctor before starting any treatment. zoey™ consultations are conducted by SMC-registered doctors in accordance with MOH telemedicine guidelines.
© 2026 zoey™ — A brand of Ordinary Folk Pte. Ltd.
Davies MJ, Bergenstal R, Bode B, et al. Efficacy of liraglutide for weight loss among patients with type 2 diabetes. JAMA. 2015;314(7):687-699. PMID: 26132939 ↩
Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989-1002. PMID: 33567185 ↩↩↩
Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387(3):205-216. PMID: 35658024 ↩↩
Articles featured on Zoey are for informational purposes only and should not be constituted as medical advice, diagnosis or treatment. If you have any medical questions or concerns, please talk to your healthcare provider. If you're looking for a healthcare provider, click here.
